Nitinol has arrived in minimally invasive glaucoma surgery, making symptom management for the progressive eye disease safer and personalized.
Schulz: When shaping the International Glaucoma Symposium 2026 agenda, we intentionally built a balanced program that reflects both core clinical practice and the rapid evolution of technology in ...
Glaucoma specialists are marking their calendars for January 31, 2026—when the 2nd International Glaucoma Symposium will take ...
Christine Funke, MD, a glaucoma specialist at Barnet Dulaney Perkins Eye Center in Phoenix, Arizona, discussed how minimally invasive glaucoma surgery (MIGS) has been able to offer her patients better ...
The MarketWatch News Department was not involved in the creation of this content.-- Initial case conducted by Dr. David Godfrey at Glaucoma Associates of Texas -- The IDE study wi ...
Please provide your email address to receive an email when new articles are posted on . Educate patients about glaucoma with nonintimidating language and details tailored to their understanding. Make ...
Morning Overview on MSN
New study flags powerful drug target that could transform glaucoma treatment
Glaucoma has long been treated as a plumbing problem of the eye, managed mainly by lowering pressure rather than protecting ...
LOVELAND, CO - January 27, 2026 - PRESSADVANTAGE - As awareness grows around early detection and management of ...
NEW ORLEANS — In patients requiring cornea transplant who have already had glaucoma surgery, Descemet membrane endothelial keratoplasty (DMEK) provides better outcomes than Descemet-stripping ...
Please provide your email address to receive an email when new articles are posted on . Ptosis and strabismus occurred in 3.7% and 1.7% of patients, respectively, and 1% had both. Most patients in all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results